Cardiac stem cell therapy has emerged as a promising approach to treat myocardial infarction (MI), commonly known as a heart attack. This therapy aims to repair damaged heart tissue and restore ...

Cardiac reprogramming and stem cell therapy are innovative fields in regenerative medicine aimed at repairing damaged heart tissue, particularly after events like myocardial infarction (heart attack).

A team of researchers led by Emory's Chunhui Xu recently found that heart muscle cells can grow and survive in the ...

Jan. 15, 2025 — While most known types of DNA damage are fixed by our cells' in-house DNA repair mechanisms, some forms of DNA damage evade repair and can persist for many years, new research shows.

A team of researchers led by the University of California San Diego and Stanford University has developed a noninvasive ...

A team of researchers led by the University of California San Diego and Stanford University has discovered a noninvasive ...

DIABETES, Parkinson's disease, degenerative disc disease, macular degeneration, stroke — what do these have in common?

For years, the Food and Drug Administration has taken up arms against clinics hawking unproven and ineffective stem cell ...

In a large-animal model study, researchers have found that heart attack recovery is aided by injection of heart muscle cell spheroids derived from human induced pluripotent stem cells, or hiPSCs ...

Ips Heart Inc. has been awarded orphan drug designation by the FDA for its GIVI-MPC stem cell therapy for Becker muscular dystrophy. GIVI-MPC has the unique ability to create new muscle with full ...